Spruce Biosciences Inc [SPRB] stock is trading at $0.56, up 1.70%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SPRB shares have gain 19.01% over the last week, with a monthly amount glided 30.52%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Spruce Biosciences Inc [NASDAQ: SPRB] stock has seen the most recent analyst activity on March 14, 2024, when RBC Capital Mkts downgraded its rating to a Sector Perform and also revised its price target to $2 from $9. Previously, Leerink Partners downgraded its rating to Market Perform on March 14, 2024, and dropped its price target to $2. On March 14, 2024, downgrade downgraded it’s rating to Neutral. H.C. Wainwright downgraded its rating to a Neutral. Guggenheim downgraded its rating to a Neutral. Guggenheim started tracking with a Buy rating for this stock on February 21, 2024, and assigned it a price target of $10. In a note dated December 17, 2021, Oppenheimer initiated an Outperform rating and provided a target price of $15 on this stock.
Spruce Biosciences Inc [SPRB] stock has fluctuated between $0.41 and $5.95 over the past year. Spruce Biosciences Inc [NASDAQ: SPRB] shares were valued at $0.56 at the most recent close of the market.
Analyzing the SPRB fundamentals
Spruce Biosciences Inc [NASDAQ:SPRB] reported sales of 9.57M for the trailing twelve months, which represents a drop of -25.64%. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -4.96%, Pretax Profit Margin comes in at -4.5%, and Net Profit Margin reading is -4.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.57, Equity is -0.6 and Total Capital is -0.78. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5344 points at the first support level, and at 0.5128 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5738, and for the 2nd resistance point, it is at 0.5916.
Ratios To Look Out For
For context, Spruce Biosciences Inc’s Current Ratio is 5.17. In addition, the Quick Ratio stands at 5.17 and the Cash Ratio stands at 4.88. Considering the valuation of this stock, the price to sales ratio is 2.40, the price to book ratio is 0.39.
Transactions by insiders
Recent insider trading involved Novo Holdings A/S, 10% Owner, that happened on Mar 21 ’24 when 0.47 million shares were sold. 10% Owner, Novo Holdings A/S completed a deal on Mar 18 ’24 to sell 0.84 million shares. Meanwhile, 10% Owner Novo Holdings A/S sold 0.59 million shares on Mar 19 ’24.
